X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
apixaban (6) 6
cost-effectiveness (6) 6
rivaroxaban (6) 6
dabigatran (5) 5
activated prothrombin complex concentrates (4) 4
female (4) 4
male (4) 4
non-valvular atrial fibrillation (4) 4
prothrombin complex concentrates (4) 4
activated factor-vii (3) 3
apixabán (3) 3
endothelium (3) 3
fibrilación auricular no valvular (3) 3
hemostasis (3) 3
hemostàsia (3) 3
human necessities (3) 3
hygiene (3) 3
medical or veterinary science (3) 3
oral anticoagulants (3) 3
preparations for medical, dental, or toilet purposes (3) 3
prothrombin complex concentrate (3) 3
recombinant factor viia (3) 3
warfarin (3) 3
àrees temàtiques de la upc (3) 3
acenocoumarol (2) 2
acetylsalicylic acid (2) 2
adhesion (2) 2
alloys (2) 2
anticoagulants (2) 2
atrial fibrillation - complications (2) 2
blood (2) 2
blood coagulation (2) 2
blood coagulation - drug effects (2) 2
blood platelets (2) 2
cardiac & cardiovascular systems (2) 2
chromium alloys - chemistry (2) 2
ciències de la salut (2) 2
coagulació sanguínia (2) 2
cost-benefit analysis (2) 2
coste-efectividad (2) 2
engineering, biomedical (2) 2
fibrin (2) 2
hemostasis - drug effects (2) 2
in-vitro (2) 2
intracerebral hemorrhage (2) 2
long-term survival (2) 2
management (2) 2
materials science, biomaterials (2) 2
medicine (2) 2
nanoscience & nanotechnology (2) 2
nonvalvular atrial fibrillation (2) 2
platelets (2) 2
prothrombin (2) 2
pyrazoles - therapeutic use (2) 2
pyridones - therapeutic use (2) 2
stroke - etiology (2) 2
stroke - prevention & control (2) 2
surgical implants (2) 2
thrombin (2) 2
thrombin generation (2) 2
thrombose (2) 2
2010 esc guidelines (1) 1
616.1 - patologia del sistema circulatori, dels vasos sanguinis. trastorns cardiovasculars (1) 1
acenocumarol (1) 1
acetylsalicylic add (1) 1
adhesion tests (1) 1
adhäsion (1) 1
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
alterations (1) 1
animals (1) 1
anticoagulants - adverse effects (1) 1
anticoagulants - pharmacology (1) 1
anticoagulants - therapeutic use (1) 1
antikoagulanz (1) 1
antithrombotic therapy (1) 1
arterials (1) 1
arterie (1) 1
arteriosclerosi (1) 1
aspirin - economics (1) 1
aspirin - therapeutic use (1) 1
assaigs clínics de medicaments (1) 1
atrial fibrillation - economics (1) 1
atrial-fibrillation (1) 1
binding (1) 1
biological activity (1) 1
biological-process (1) 1
biologischer prozess (1) 1
biomaterials (1) 1
blood circulation (1) 1
blood coagulation factors - pharmacology (1) 1
blood coagulation factors - therapeutic use (1) 1
blood compatibility (1) 1
blood platelets - cytology (1) 1
blood platelets - metabolism (1) 1
blood platelets - physiology (1) 1
blood vessel prosthesis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ISSN 1932-6203, 08/2012
Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney disease (CKD). The elevated frequency of atherothrombotic events... 
Malalties del ronyó | Kidney diseases | Uremia | Urèmia | Endoteli | Endothelium
Journal Article
Atencion Primaria, ISSN 0212-6567, 06/2016, Volume 48, Issue 6, pp. 394 - 405
Objective To assess the cost-effectiveness of apixaban versus acetylsalicylic acid (ASA) in stroke prevention in patients with non-valvular atrial fibrillation... 
Acetylsalicylic acid | Cost-effectiveness | Non-valvular atrial fibrillation | Apixaban
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e78696
Journal Article
Journal Article
MICROMACHINES, ISSN 2072-666X, 08/2019, Volume 10, Issue 8, p. 534
Journal Article
Advanced Healthcare Materials, ISSN 2192-2640, 10/2017, Volume 6, Issue 19, pp. 1700327 - n/a
Journal Article
Revista Espanola de Cardiologia, ISSN 0300-8932, 08/2015, Volume 68, Issue 8, pp. 680 - 690
Introduction and objectives Cost-effectiveness analysis of apixaban (5 mg twice daily) vs acenocoumarol (5 mg/day) in the prevention of stroke in patients with... 
Cost-effectiveness | Nonvalvular atrial fibrillation | Apixaban | Acenocoumarol
Journal Article
Journal Article
Atención Primaria, ISSN 0212-6567, 2015, Volume 48, Issue 6, pp. 394 - 405
Resumen Objetivo Evaluar el coste-utilidad de apixabán frente al ácido acetilsalicílico (AAS) en la prevención del ictus en pacientes con fibrilación auricular... 
Internal Medicine | Ácido acetilsalicílico | Coste-utilidad | Non-valvular atrial fibrillation | Apixabán | Apixaban | Acetylsalicylic acid | Cost-effectiveness | Fibrilación auricular no valvular
Journal Article
DE LA TESIS:El término "arteriosclerosis" debe atribuirse a Lobstein, que lo creó en 1833 para referirse a lo que él denominaba: "un aumento del espesor y la... 
Arteriosclerosi | Malalties cardiovasculars | Envelliment - Fisiologia | 616.1 - Patologia del sistema circulatori, dels vasos sanguinis. Trastorns cardiovasculars | Ciències de la Salut
Dissertation
07/2014
Sales de tungstato como agentes antiplaquetarios. Las sales de tungstato con cationes farmacéuticamente aceptables o sus solvatos son útiles para reducir la... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
06/2014
Tungstate salts of pharmaceutically acceptable metals, or the solvates thereof, are useful for reducing the reactivity of platelets in a mammal, including a... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
Journal Article
Circulation Journal, ISSN 1346-9843, 2015, Volume 79, Issue 2, pp. 331 - 338
Background:Despite the good safety of rivaroxaban, there is limited information on strategies for urgent reversal of its antihemostatic effects.Methods and... 
Rivaroxaban | Recombinant factor VIIa | Prothrombin complex concentrates | Activated prothrombin complex concentrates
Journal Article
Circulation Journal, ISSN 1346-9843, 2014
Background:Despite the good safety of rivaroxaban, there is limited information on strategies for urgent reversal of its antihemostatic effects.Methods and... 
Rivaroxaban | Prothrombin complex concentrates | Recombinant factor VIIa | Activated prothrombin complex concentrates
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.